MedTrace Logo

Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department

NCT05325112 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-05-22

No results posted yet for this study

Summary

This is a prospective multi-center study. All clinically stable, symptomatic patients who present to the emergency department (ED) or observation unit with suspected coronary artery disease (CAD) and who have at least one ≥40% lesion and no lesion \>90% confirmed by CCTA (Coronary Computed Tomography Angiogram) are eligible for enrollment once their CCTA has been completed and their FFR-CT (if applicable) has been ordered. All enrolling sites will have CCTA incorporated into their standard evaluation of chest pain in the ED/observation unit. Non-control sites will have CCTA and FFR-CT analysis incorporated into their standard evaluation of chest pain in the ED/observation unit.

Conditions

Interventions

DIAGNOSTIC_TEST

FFR-CT

FFR-CT is a diagnostic test following a CCTA to help diagnose and treat coronary artery disease.

Sponsors & Collaborators

  • HeartFlow, Inc.

    lead INDUSTRY

Principal Investigators

  • Sadeer Al-Kindi, MD · University Hospitals Cleveland

  • Sneha Chinai, MD · UMass Memorial Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2022-11-14
Completion
2022-11-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05325112 on ClinicalTrials.gov